Dermatological adverse events from BRAF inhibitors: A growing problem Journal Article


Authors: Belum, V. R.; Fischer, A.; Choi, J. N.; Lacouture, M. E.
Article Title: Dermatological adverse events from BRAF inhibitors: A growing problem
Abstract: The development of targeted therapies has ushered in a new era in the management of melanoma. Inhibitors of the RAS-RAF-MEK-ERK pathway have taken the center stage with development at a rapid pace. Vemurafenib was recently approved by regulatory agencies, and other agents (e.g. dabrafenib) are in various stages of clinical testing. These agents are producing remarkable results for patients, but are also presenting new challenges. Clinical toxicities and drug resistance are topmost issues. Some of the most common and vivid representations of adverse events to these agents are the dermatologic manifestations. Published trials and initial observations reflect a toxicity profile (e.g. squamous cell carcinomas/keratoacanthomas, maculopapular rashes, hyperkeratosis) that is distinct from cutaneous toxicities from EGFR and mTOR inhibitors (acneiform rash, paronychia, xerosis). Their management extends beyond conservative treatment and includes specific physical and surgical treatment modalities, skill sets unique to dermatologists. All these pose significant challenges to clinicians, and sound knowledge of such toxicities and their management will likely result in improved patient outcomes and quality of life. In this manuscript, we provide an overview of the emerging scientific literature on dermatological adverse events arising out of BRAF inhibition. © 2013 Springer Science+Business Media New York.
Keywords: sorafenib; hand foot skin reaction; pruritus; rash; papilloma; alopecia; photosensitivity; keratoacanthoma; dermatologic; vemurafenib; dabrafenib; scc; braf inhibition; melanocytic proliferations; squamoproliferative; verruca; verrucous keratoses; wt-braf
Journal Title: Current Oncology Reports
Volume: 15
Issue: 3
ISSN: 1523-3790
Publisher: Springer  
Date Published: 2013-06-01
Start Page: 249
End Page: 259
Language: English
DOI: 10.1007/s11912-013-0308-6
PROVIDER: scopus
PUBMED: 23463215
DOI/URL:
Notes: --- - "Export Date: 3 June 2013" - "CODEN: CORUA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture
  2. Viswanath Reddy Belum
    38 Belum